These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 23435515)
1. Bronchiolitis obliterans after allogeneic hematopoietic SCT: further insight--new perspectives? Ditschkowski M; Elmaagacli AH; Koldehoff M; Gromke T; Trenschel R; Beelen DW Bone Marrow Transplant; 2013 Sep; 48(9):1224-9. PubMed ID: 23435515 [TBL] [Abstract][Full Text] [Related]
2. Lower incidence of Bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning. Yoshihara S; Tateishi U; Ando T; Kunitoh H; Suyama H; Onishi Y; Tanosaki R; Mineishi S Bone Marrow Transplant; 2005 Jun; 35(12):1195-200. PubMed ID: 15852024 [TBL] [Abstract][Full Text] [Related]
3. Donor lymphocyte infusion may reduce the incidence of bronchiolitis obliterans after allogeneic stem cell transplantation. Forslöw U; Mattsson J; Gustafsson T; Remberger M Biol Blood Marrow Transplant; 2011 Aug; 17(8):1214-21. PubMed ID: 21193056 [TBL] [Abstract][Full Text] [Related]
4. Late-onset non-infectious pulmonary complications following allogeneic hematopoietic stem cell transplantation in children. Nishio N; Yagasaki H; Takahashi Y; Muramatsu H; Hama A; Tanaka M; Yoshida N; Watanabe N; Kudo K; Yoshimi A; Kojima S Bone Marrow Transplant; 2009 Sep; 44(5):303-8. PubMed ID: 19349954 [TBL] [Abstract][Full Text] [Related]
5. Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: a single-center experience. Vogl UM; Nagayama K; Bojic M; Hoda MA; Klepetko W; Jaksch P; Dekan S; Siersch V; Mitterbauer M; Schellongowski P; Greinix HT; Petkov V; Schulenburg A; Kalhs P; Rabitsch W Transplantation; 2013 Feb; 95(4):623-8. PubMed ID: 23274967 [TBL] [Abstract][Full Text] [Related]
6. Identification of risk factors for bronchiolitis obliterans syndrome after reduced toxicity conditioning before hematopoietic cell transplantation. Duque-Afonso J; Ihorst G; Wäsch R; Bertz H; Müller-Quernheim J; Finke J; Prasse A; Marks R Bone Marrow Transplant; 2013 Aug; 48(8):1098-103. PubMed ID: 23376822 [TBL] [Abstract][Full Text] [Related]
7. Decreased serum levels of clara cell secretory protein (CC16) are associated with bronchiolitis obliterans and may permit early diagnosis in patients after allogeneic stem-cell transplantation. Mattsson J; Remberger M; Andersson O; Sundberg B; Nord M Transplantation; 2005 May; 79(10):1411-6. PubMed ID: 15912112 [TBL] [Abstract][Full Text] [Related]
8. A case-control study of bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation. Nakasone H; Kanda J; Yano S; Atsuta Y; Ago H; Fukuda T; Kakihana K; Adachi T; Yujiri T; Taniguchi S; Taguchi J; Morishima Y; Nagamura T; Sakamaki H; Mori T; Murata M; Transpl Int; 2013 Jun; 26(6):631-9. PubMed ID: 23551210 [TBL] [Abstract][Full Text] [Related]
9. Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. Santo Tomas LH; Loberiza FR; Klein JP; Layde PM; Lipchik RJ; Rizzo JD; Bredeson CN; Horowitz MM Chest; 2005 Jul; 128(1):153-61. PubMed ID: 16002929 [TBL] [Abstract][Full Text] [Related]
10. Comparison of pulmonary complications after nonmyeloablative and conventional allogeneic hematopoietic cell transplant. Diab KJ; Yu Z; Wood KL; Shmalo JA; Sheski FD; Farber MO; Wilkes DS; Nelson RP Biol Blood Marrow Transplant; 2012 Dec; 18(12):1827-34. PubMed ID: 22766224 [TBL] [Abstract][Full Text] [Related]
11. Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation. Nakaseko C; Ozawa S; Sakaida E; Sakai M; Kanda Y; Oshima K; Kurokawa M; Takahashi S; Ooi J; Shimizu T; Yokota A; Yoshiba F; Fujimaki K; Kanamori H; Sakai R; Saitoh T; Sakura T; Maruta A; Sakamaki H; Okamoto S Int J Hematol; 2011 Mar; 93(3):375-382. PubMed ID: 21424350 [TBL] [Abstract][Full Text] [Related]
13. Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT. Lucid CE; Savani BN; Engelhardt BG; Shah P; Clifton C; Greenhut SL; Vaughan LA; Kassim A; Schuening F; Jagasia M Bone Marrow Transplant; 2011 Mar; 46(3):426-9. PubMed ID: 20581885 [TBL] [Abstract][Full Text] [Related]
14. T-cell depletion prevents from bronchiolitis obliterans and bronchiolitis obliterans with organizing pneumonia after allogeneic hematopoietic stem cell transplantation with related donors. Ditschkowski M; Elmaagacli AH; Trenschel R; Peceny R; Koldehoff M; Schulte C; Beelen DW Haematologica; 2007 Apr; 92(4):558-61. PubMed ID: 17488669 [TBL] [Abstract][Full Text] [Related]
15. Serum Krebs Von Den Lungen-6 as a Biomarker for Early Detection of Bronchiolitis Obliterans Syndrome in Children Undergoing Allogeneic Stem Cell Transplantation. Gassas A; Schechter T; Krueger J; Craig-Barnes H; Sung L; Ali M; Dell S; Egeler RM; Zaidman I; Palaniyar N Biol Blood Marrow Transplant; 2015 Aug; 21(8):1524-8. PubMed ID: 25963919 [TBL] [Abstract][Full Text] [Related]